{"filing":{"accession_number":"0000885590-26-000105","cik":"0000885590","ticker":"BHC","company_name":"Bausch Health Companies Inc.","form":"8-K","filing_date":"2026-07-29","report_date":"2026-07-29","primary_document":"bhc-20260729.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/885590/000088559026000105/bhc-20260729.htm"},"events":[{"id":21643,"run_id":19522,"accession_number":"0000885590-26-000105","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"summary":"Bausch Health issued a press release on July 29, 2026 announcing second quarter 2026 financial results, including consolidated revenues of $2.85 billion (up 13% reported, 11% organic), GAAP net income of $258 million, and adjusted EPS of $1.26 (up 40% year-over-year). The company also raised full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted cash flows. This is a standard quarterly earnings release with material financial metrics and forward guidance.","company_name":"Bausch Health Companies Inc.","ticker":"BHC","filing_date":"2026-07-29","form":"8-K","submitted_at":null,"items":[{"id":21332,"accession_number":"0000885590-26-000105","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Bausch Health issued a press release on July 29, 2026 announcing second quarter 2026 financial results, including consolidated revenues of $2.85 billion (up 13% reported, 11% organic), GAAP net income of $258 million, and adjusted EPS of $1.26 (up 40% year-over-year). The company also raised full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted cash flows. This is a standard quarterly earnings release with material financial metrics and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:18:01.260956+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":21332,"accession_number":"0000885590-26-000105","item_number":"2.02","item_title":"Results of Operations and Financial Condition.","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Bausch Health issued a press release on July 29, 2026 announcing second quarter 2026 financial results, including consolidated revenues of $2.85 billion (up 13% reported, 11% organic), GAAP net income of $258 million, and adjusted EPS of $1.26 (up 40% year-over-year). The company also raised full-year 2026 guidance for revenue, adjusted EBITDA, and adjusted cash flows. This is a standard quarterly earnings release with material financial metrics and forward guidance.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-29T20:18:01.260956+00:00","company_name":"Bausch Health Companies Inc.","ticker":"BHC","filing_date":"2026-07-29"}]}
